Currently, a method called "Check-up" is known (1). Check-up is a comprehensive examination of the body, which is selected for each patient's request. Depending on the program, the check-up may include blood tests, ultrasound, MRI, CT, cardiogram, consultations with specialists, including dentists, phlebologists or other highly specialized doctors.

As a rule, the check-up includes an examination of all major body systems: cardiovascular, endocrine, digestive, respiratory, nervous. The patient can choose a specific program, for example, cardio-, onco-, female or male check-up.

Also, the set of examinations depends on the patient's age. The main objective of the check-up is to detect the disease at the earliest stage, while there are no symptoms, namely, while the patient feels relatively normal, and also to control existing chronic diseases.

The examination does not provide for, does not include the principle of treatment of the patient who has some deviation from the norm. At the same time, the doctor who conducts the examination refers the patient to a specialist for appropriate treatment.

Unlike the check-up, our approach to effective prevention includes both examination and treatment of patients. What is the main difference between our approach and the check-up?

The main principle of our approach consists in bio resonance assessment of the potency of various organs in which the pathological process can develop. Reduced potency of any human organ leads to the fact that it is in this organ that the pathological process begins to develop, including oncological. After detecting decreased potency, the doctor's task is to normalize the potency of this detected organ so that a pathological process, including oncological disease, does not occur in this organ. Over the course of our many years of research, it has been established that an oncological process or any other pathological process occurs only in the organ whose potency is decreased and is detected, in particular, using computer, bio resonance studies in humans of different ages.

The device for bio resonance therapy has a built-in electronic drug selector, which contains more than fifty thousand electronic analogues of human diseases, as well as organ preparations, allergens from various companies.

Patients (24 patients) were examined using bio resonance therapy (device for bio resonance therapy from IMEDIS) of various human organs of different ages. In middle-aged patients (18-50 years old), the organs where the oncological process occurs were examined - the brain, thyroid gland, mammary gland (in women), lungs, stomach, pancreas, spleen, small and large intestines, uterus (in women), prostate gland, blood, skeletal system, skin, eyes (visual organs), kidneys.

In cases where normal potency is detected, characteristic of a given age and gender, these identified normal parameters are entered into the examination protocol and no further actions are taken. In the same cases (16 patients), when a potency reduced compared to normal is detected, it is entered into the protocol and the necessary actions are then taken to normalize the organ's potency.

In the previous work (3), a method for converting inactive nosodes into active ones was presented. For this purpose, the principle of resonance of creation^1-16 was used. We understand quite clearly that pathological changes, including oncological processes, can develop in an organ with reduced potency.

The doctor's task is not only to detect reduced potency in the organ being examined, but also to normalize this potency. For this purpose, various potencies, including high potency, are supplied to this organ. The process of supplying high potencies is completed when the organ with reduced potency becomes completely normal, i.e. with normal potency. This is precisely what prevents the occurrence of diseases, including oncological diseases, consists of.

Let's give examples. Example 1. A 78-year-old patient has reduced potency of the stomach.

When testing the stomach or some other organ, the doctor understands that in the initial state, in healthy people, the level of potency of the organ being tested is completely normal. And it is in relation to this normal level of potency that the level of potency in altered states is compared.

So, our During the examination of the patient - after the treatment with the X-ray method, a decreased potency of the stomach was detected, which was extremely dangerous due to the possibility of recurrence of stomach cancer. In order to prevent the occurrence of recurrent stomach cancer, we had to increase (normalize) the potency of the stomach, which we did. We brought a high potency of 50 to the patient's "stomach" nosode. In this case, the "stomach" nosode in our patient became completely normal. Under these conditions, the possibility of stomach cancer is completely excluded. In addition, we changed the potency of stomach cancer, as a result of which the "stomach cancer" nosode ceased to be tested, i.e. stomach cancer was cured. Indeed, if the potency of a pathological nosode is normalized, it ceases to be a tissue with its altered "sick" level of potency. The potency level of a tissue nosode is determined by the genetic apparatus of this tissue. By changing the potency of a tissue nosode, we interfere with the activity of the genetic apparatus of this tissue. By changing the potency level of the tissue nosode, we actually change the nature of the activity of the tissue's genetic apparatus.

Thus, by changing the potency of the tumor nosode, cancer, we change its function - it ceases to be a tumor and dies. For more than 3 years after the treatment, we tested the "stomach cancer" nosode in this patient. During this time, the nosode was not tested. Therefore, stomach cancer was cured.

Example 2. A patient who had suffered from thyroid cancer for 4 years came to us. We examined this patient and found a low level of thyroid potency and an oncological process in the thyroid gland. We clearly understand that if the patient had a normal level of thyroid potency, the oncological process would not have arisen in the organ. We performed two actions. The first one cured the oncological process in the thyroid gland in the same way as we cured it before (2). Next, we normalized the level of potency in the thyroid gland so that the oncological process would not develop in this organ. It is clear that after the normalization of the level of potency in the thyroid gland, it is impossible for any pathological process, including oncological disease, to develop in it. For more than 3 years after the treatment, we tested the nosode "thyroid cancer" in this patient. During this time, the nosode was not tested. Therefore, thyroid cancer was cured.

Summarizing the conducted research, it should be noted that the normalization of the potency of various organs excludes the possibility of the occurrence of an oncological process or some other disease in these organs. This is precisely what prevention of oncological diseases consists of.

Normalization of the potency of various organs in elderly people leads not only to the prevention of the occurrence of a pathological process in them, but also helps to increase the life expectancy of patients.

It is now well known that people over 50 years of age begin to experience a decrease in the potency of various organs and organ systems. This circumstance leads to the occurrence of various diseases and ultimately to the end of the life process. That is why normalization of the potency of various organs in elderly people (18 patients) by a doctor can lead not only to the prevention of various diseases, including cancer, but also to an increase in their life expectancy.

Example. We found that in an 84-year-old patient, various organs are tested in a reduced potency compared to young and middle-aged people. Similar changes were found in other subjects (18 subjects). The above is the reason for the occurrence of various diseases in these patients and the end of the life process.

In order to prevent the occurrence of a pathological process in them, as well as to increase life expectancy, we had to normalize the level of potency in various organs. To do this, we brought a high potency of 50 to each organ under study, which led to the normalization of the level of potency in our patients.

The above not only led to the prevention of various diseases, including cancer, but also to an increase in their life expectancy in the future.¹⁷

Normalization of the organ's potency leads to the fact that it ceases to be tissue with its altered "sick" level of potency. This is the prevention of diseases, including cancer.

Changing the potency of the tumor nosode, cancer, changes its function - it ceases to be a tumor and dies.

Normalization of an organ with low potency is a factor in increasing human life expectancy.

None.

None declared.

1. Praznikov V. The use of nosodes with healthcare manager. 2025: 05-14: 377.
2. Praznikov V. How to change the potency of  Disease Nosode Change the Course of the Disease Itself. Journal of Clinical Case Studies Reviews and Reports.  2024: 06.
3. Praznikov V. Resonance medicine. international journal of medical science and clinical invention. 2022;9(2):5962–5973.
4. Praznikov V. Diagnostics and Treatment of Multiple Sclerosis by the Method of Resonance Medicine/ Austin Journal of Multiple Sclerosis and Neuroimmunology. 2022;6(10):1034.
5. Praznikov V. Resonance medicine as a method of augmentation life expectancy. International Journal of Gerontology and Geriatric Research. 2022;6(1):001-004.
6. Praznikov V. Diagnosis and treanment of children cerebral palsy with method resonance medicine. Biomedical Research and Enviripmental Sciences. 2022;3(9).
7. Praznikoov V. Effective treanment of chronic neuritis of auditory nerve with resonance therapy. Online Journal of Otolaringoligy and Rhinoloigy. 2022;5(4).
8. Praznikov V. Effective treatment for retinal and lens degeneration with resonance medicine metyod.  Journal of Biomedical Reseach and Environmental Sciences. Ophthalmology. 2022;3(9):1069-1075.
9. Praznikov V. Effective AIDS treatment with resonance medicine. World ISSN 2688-8548, p. 1-4 2022. Orthopedics: Research and Therapy.  2022;5(1):006-010.
10. Praznikov V. Effective treatment of diabetes mellitus and autoimmune diseases dy resonance medicine.  Journal  of Research in Diabetes and Metabolism 2022;8(1):005-0010.
11. Praznikov V. Diagnosis and treatment of alzheimer disease and parkinson disease with resonance medicine. journal of biomedical research and environmental sciences. Alzheimer and Parkinson disease. 2022;3(9):1000-1010.
12. Praznikov V. Diagnosis and treanment of children cerebral palsy with method resonance medicine. Biomedical Research and Enviripmental Sciences. Pediatrics  Brain Disordes. 2022;9(3).
13. Praznikoov V. Effective treanment of chronic neuritis of auditory nerve with resonance therapy. Online Journal of Otolaringoligy and Rhinoloigy . 2022;5(4).
14. Praznikov V. Effective treatment for retinal and lens degeneration with resonance medicine metyod.  Journal of Biomedical Reseach and Environmental Sciences. Ophthalmology.  2022;3(9):1069-1075.
15. Praznikov V. Effective gout treatment with resonance therapy. International Journal of  Research and Therapy.  2022;26:5(1):006-010.
16. Praznikov V. Resonance medicine as a method of augmentation life expectancy. International Journal of Gerontology and Geriatric Research. 2022;1-4.
17. Praznikov V.  Multiple sclerosis as a cause of disturbances in the activity of the heart and brain;  the role of glycine and n-acetylcysteine  in treatment and prevention of these conditions in the elderly using resonance therapy. Sun Text Review of Medical and Clinical Research. 2023;4(2):179.